New drug application(NDA)

For any suggestion mail at "[email protected]" Insta: dearpharmasquare New Drug Application (NDA) has been the basis for the control and regulation of new drug in the US for decades. NDA is a means through which the pharma sponsors formally propose to the FDA to approve a new drug for sale and marketing in the U.S. It contains the data gathered during the animal studies and human clinical trials of an Investigational New Drug (IND). The objective of the NDA is to offer sufficient information to permit FDA reviewer to reach the following key decisions: Whether the drug is safe and effective in its proposed use(s), and whether the benefits of the drug outweigh the risks. Whether the drugs’ proposed labeling (package insert) is appropriate, and what it should contain. Whether the methods used in manufacturing the drug and the controls used to maintain the drug's quality are adequate to preserve the drug's identity, strength, quality, and purity. The documentation required in an NDA provides the following information about the drug: what happened during the clinical tests what the ingredients of the drug are the results of the animal studies how the drug behaves in the body how it is manufactured, processed and packaged